TargetMol

R 396

Product Code:
 
TAR-T24697
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24697-1mg1mg£401.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24697-5mg5mg£780.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24697-10mg10mg£1,135.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24697-25mg25mg£1,915.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
R 396 is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.
CAS:
129809-09-2
Formula:
C39H51N9O10
Molecular Weight:
805.89
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.98
SMILES:
CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(N)=O
Target:
Neurokinin receptor

References

1. Pluck G. Preliminary Validation of a Free-to-Use, Brief Assessment of Adult Intelligence for Research Purposes: The Matrix Matching Test. Psychol Rep. 2018 Jan 1:33294118762589. doi: 10.1177/0033294118762589. [Epub ahead of print] PubMed PMID: 29540106. 2. Giannouli E, Bock O, Zijlstra W. Cognitive functioning is more closely related to real-life mobility than to laboratory-based mobility parameters. Eur J Ageing. 2017 Jun 20;15(1):57-65. doi: 10.1007/s10433-017-0434-3. eCollection 2018 Mar. PubMed PMID: 29531515; PubMed Central PMCID: PMC5840094. 3. Karde? S, Karag?lle M, Durak ?, Avc? A, Karag?lle MZ. Association of oxidative stress with clinical characteristics in patients with rheumatoid arthritis. Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12858. Epub 2017 Dec 8. PubMed PMID: 29144558. 4. Anyfanti P, Triantafyllou A, Gkaliagkousi E, Koletsos N, Athanasopoulos G, Zabulis X, Galanopoulou V, Aslanidis S, Douma S. Retinal vessel morphology in rheumatoid arthritis: Association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk. Microcirculation. 2017 Nov;24(8). doi: 10.1111/micc.12417. PubMed PMID: 28926162.